Table 2.
Assess for conditions that may reduce efficacy or increase harm from NIV, including hemodynamic instability, multiple organ failure, abdominal distension, agitation, excessive secretions, or upper GI bleeding. |
Ensure appropriate mask fit. Most critically ill patients require oronasal or full-face masks. |
Monitor and minimize leak. |
Set initial bi-level PAP settings at 10/5 cm H2O to promote tolerance, but reassess frequently. Most patients require higher inspiratory and expiratory pressures to treat OSA and to achieve adequate ventilation. |
Titrate IPAP to achieve effective minute ventilation (tidal volume of 6-8 mL/kg ideal body weight). |
Administer supplemental oxygen to achieve saturation between 90% and 93%. (In a subgroup of patients with COPD and OHS excessive oxygen supplementation can worsen hypoventilation).79-82 |
Reassess patients at least every 30 min during the initial phase of NIV. |
Monitor closely for NIV failure. Potential signs include hemodynamic instability, agitation, combativeness, persistent snoring or apneas, or lack of improvement in hypercapnia or hypoxia. |
IPAP = inspiratory positive airway pressure; PAP = positive airway pressure. See Table 1 legend for expansion of other abbreviations.